Cyclooxygenase-2 inhibition enhances proliferation of NKT cells derived from patients with laryngeal cancer
Anticancer Research Aug 10, 2017
Klatka J, et al. – The researchers intended to figure out whether inhibition of cyclooxygenase–2 by celecoxib and the subsequent enhancement in the proliferation of natural killer T (NKT) cells could play a role in dendritic cell (DC)–based laryngeal cancer (LC) immunotherapy. They suggested that COX–2 inhibition could be considered as the immunotherapy–enhancing tool in patients with LC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
